218 related articles for article (PubMed ID: 23763409)
21. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
[TBL] [Abstract][Full Text] [Related]
22. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
23. The Impact of Varying Numbers of Quadrivalent Human Papillomavirus Vaccine Doses on Anogenital Warts in the United States: A Database Study.
Zeybek B; Lin YL; Kuo YF; Rodriguez AM
J Low Genit Tract Dis; 2018 Jul; 22(3):189-194. PubMed ID: 29762430
[TBL] [Abstract][Full Text] [Related]
24. PREVALENCE AND CLINICAL MANIFESTATIONS OF MALE PATIENTS WITH ANOGENITAL WARTS ATTENDING A SEXUALLY TRANSMITTED DISEASE CLINIC PRIOR HPV VACCINE RECOMMENDATION.
Jiamton S; Leeyaphan C; Maneeprasopchoke P; Omcharoen V
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1337-43. PubMed ID: 26466419
[TBL] [Abstract][Full Text] [Related]
25. Genital Wart and Human Papillomavirus Prevalence in Men in the United States From Penile Swabs: Results From National Health and Nutrition Examination Surveys.
Daugherty M; Byler T
Sex Transm Dis; 2018 Jun; 45(6):412-416. PubMed ID: 29750774
[TBL] [Abstract][Full Text] [Related]
26. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
[TBL] [Abstract][Full Text] [Related]
27. Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus Vaccination.
Naleway AL; Crane B; Smith N; Francisco M; Weinmann S; Markowitz LE
Sex Transm Dis; 2020 Mar; 47(3):179-186. PubMed ID: 31880738
[TBL] [Abstract][Full Text] [Related]
28. The impact of anogenital warts on health-related quality of life: a 6-month prospective study.
Drolet M; Brisson M; Maunsell E; Franco EL; Coutlée F; Ferenczy A; Ratnam S; Fisher W; Mansi JA
Sex Transm Dis; 2011 Oct; 38(10):949-56. PubMed ID: 21934571
[TBL] [Abstract][Full Text] [Related]
29. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis.
Denecke A; Iftner T; Iftner A; Riedle S; Ocak M; Luyten A; Üye I; Tunc K; Petry KU
BMC Infect Dis; 2021 Jul; 21(1):634. PubMed ID: 34215215
[TBL] [Abstract][Full Text] [Related]
30. Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.
Canvin M; Sinka K; Hughes G; Mesher D
Sex Transm Infect; 2017 Mar; 93(2):125-128. PubMed ID: 27365492
[TBL] [Abstract][Full Text] [Related]
31. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
Brotons M; Monfil L; Roura E; Duarte-Salles T; Casabona J; Urbiztondo L; Cabezas C; Bosch FX; de Sanjosé S; Bruni L
Prev Med; 2020 Sep; 138():106166. PubMed ID: 32565118
[TBL] [Abstract][Full Text] [Related]
32. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
Woestenberg PJ; Guevara Morel AE; Bogaards JA; Hooiveld M; Schurink-van 't Klooster TM; Hoebe CJPA; van der Sande MAB; van Benthem BHB
Clin Infect Dis; 2021 Jul; 73(2):291-297. PubMed ID: 32421775
[TBL] [Abstract][Full Text] [Related]
33. Anogenital warts knowledge and counseling practices of US clinicians: results from a national survey.
Henderson Z; Irwin KL; Montaño DE; Kasprzyk D; Carlin L; Greek A; Freeman C; Barnes R; Jain N
Sex Transm Dis; 2007 Sep; 34(9):644-52. PubMed ID: 17413682
[TBL] [Abstract][Full Text] [Related]
34. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
Donovan B; Franklin N; Guy R; Grulich AE; Regan DG; Ali H; Wand H; Fairley CK
Lancet Infect Dis; 2011 Jan; 11(1):39-44. PubMed ID: 21067976
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data.
Ali H; McManus H; O'Connor CC; Callander D; Kong M; Graham S; Saulo D; Fairley CK; Regan DG; Grulich A; Low N; Guy RJ; Donovan B
Med J Aust; 2017 Mar; 206(5):204-209. PubMed ID: 28301790
[TBL] [Abstract][Full Text] [Related]
37. Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.
McCormack PL; Joura EA
Drugs; 2010 Dec; 70(18):2449-74. PubMed ID: 21142263
[TBL] [Abstract][Full Text] [Related]
38. Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007-2010.
Bauer HM; Wright G; Chow J
Am J Public Health; 2012 May; 102(5):833-5. PubMed ID: 22420808
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of other sexually transmissible infections in patients with newly diagnosed anogenital warts in a sexual health clinic.
Sturgiss EA; Jin F; Martin SJ; Grulich A; Bowden FJ
Sex Health; 2010 Mar; 7(1):55-9. PubMed ID: 20152097
[TBL] [Abstract][Full Text] [Related]
40. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
Vaccine; 2016 Sep; 34(39):4678-4683. PubMed ID: 27527815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
